SEC Filing Details

SEC Filing Details

Document Details

Form
DRS
Filing Date
Aug 4, 2016
Document Date
Aug 4, 2016
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
RESHAPE LIFESCIENCES INC.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE